scholarly journals LTX-315 – a promising novel antitumor peptide and immunotherapeutic agent

Cell Stress ◽  
2019 ◽  
Vol 3 (11) ◽  
pp. 328-329
Author(s):  
Dagmar Zweytick
Keyword(s):  
Immunotherapeutic Agent

scholarly journals Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent

2017 ◽  
Vol 8 (1) ◽  
Author(s):  
Pengju Wang ◽  
Xiaozhu Li ◽  
Jiwei Wang ◽  
Dongling Gao ◽  
Yuenan Li ◽  
...  
Keyword(s):  
Interleukin 12 ◽  
Immunotherapeutic Agent

scholarly journals Effectiveness of measles, mumps and rubella vaccine as immunotherapeutic agent for cutaneous viral warts

2020 ◽  
Vol 6 (3) ◽  
pp. 439
Author(s):  
Anupama Devi Wahengbam ◽  
Jeyakumari Jeevan ◽  
Sowmya Dogiparthi
Keyword(s):  
Clinical Studies ◽  
Single Agent ◽  
Complete Response ◽  
Mmr Vaccine ◽  
Rubella Vaccine ◽  
Immunotherapeutic Agent ◽  
Management Evaluation ◽  
Cutaneous Wart ◽  
Short Narrative ◽  
Cutaneous Warts

<p>Immunotherapy for management of cutaneous wart with measles, mumps and rubella vaccine (MMR) is a promising new modality of management. Evaluation of the same has been done by various studies over the years reporting its effectiveness. A literature search was done using PubMed and google scholar. This short narrative review documents the response rates in various clinical studies done till 2019 which have reported the efficacy of MMR vaccine as an immunotherapeutic agent which ranged from 26-84% graded as complete response which is complete clearance of the treated warts. These studies were performed for evaluating MMR vaccine as single agent or done in comparison with other therapeutic agents. The broad range of responses points to a need of doing further clinical studies which will substantiate the effectiveness of MMR vaccine in the treatment of cutaneous warts.</p>

Harnessing Se=N to develop novel fluorescent probes for visualizing the variation of endogenous hypobromous acid (HOBr) during the administration of immunotherapeutic agent

2021 ◽  
Author(s):  
Jian Zhang ◽  
kaiqiang Liu ◽  
Jingwen Li ◽  
Yingying Xie ◽  
Yong Li ◽  
...  
Keyword(s):  
Fluorescent Probes ◽  
Live Cells ◽  
Immunotherapeutic Agent ◽  
Hypobromous Acid ◽  
In Virtue Of

In virtue of the formation of Se=N, ABT-Se and NDI-Se were developed to detect and visualize endogenous HOBr in live cells. Specifically, the upregulation of HOBr was monitored by NDI-Se...

scholarly journals Mice with Pulmonary Tuberculosis Treated with Mycobacterium vaccae Develop Strikingly Enhanced Recall Gamma Interferon Responses to M. vaccae Cell Wall Skeleton

2008 ◽  
Vol 15 (5) ◽  
pp. 893-896 ◽  
Author(s):  
Elisabeth Rodríguez-Güell ◽  
Gemma Agustí ◽  
Mercè Corominas ◽  
Pere-Joan Cardona ◽  
Marina Luquin ◽  
...  
Keyword(s):  
Cell Wall ◽  
Pulmonary Tuberculosis ◽  
Gamma Interferon ◽  
Subcellular Fractions ◽  
Mycobacterium Vaccae ◽  
Immunotherapeutic Agent ◽  
Interferon Responses

ABSTRACT Whole heat-killed Mycobacterium vaccae is used as an immunotherapeutic agent in tuberculosis (TB), but the compound(s) that triggers its immunostimulatory ability is not known. Here, we show that among different subcellular fractions, the cell wall skeleton induced a prominent expression of gamma interferon in splenocytes from both non-TB and TB M. vaccae-treated mice.

scholarly journals Author Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent

2018 ◽  
Vol 9 (1) ◽  
Author(s):  
Pengju Wang ◽  
Xiaozhu Li ◽  
Jiwei Wang ◽  
Dongling Gao ◽  
Yuenan Li ◽  
...  
Keyword(s):  
Interleukin 12 ◽  
Immunotherapeutic Agent
Sign in / Sign up

Export Citation Format

Share Document